Biogen Idec (BIIB) Tops Q4 EPS by 31c
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $197.19 -1.26%
EPS Growth %: -41.3%
Financial Fact:
Restructuring charge: 11.6M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -41.3%
Financial Fact:
Restructuring charge: 11.6M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Biogen Idec (NASDAQ: BIIB) reported Q4 EPS of $4.09, $0.31 better than the analyst estimate of $3.78. Revenue for the quarter came in at $2.6 billion versus the consensus estimate of $2.64 billion.
Biogen Idec sees FY2015 EPS of $16.60-$17.00, versus the consensus of $16.37.
For earnings history and earnings-related data on Biogen Idec (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
